Autres langues Entrada Therapeutics, Inc.

Actions

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 23/04/2024			Varia. 5j.	Varia. 1 janv.
12,89 ^USD	-1,60 %		+1,34 %	-14,58 %

13/03	Entrada Therapeutics, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI
13/03	Entrada Therapeutics, Inc. annonce ses résultats pour le quatrième trimestre clos le 31 décembre 2023	CI

Entrada Therapeutics : Corporate Presentation	13/03
Entrada Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	13/03
Entrada Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	13/03
Entrada Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results	13/03
North American Morning Briefing : Stock Futures -2-	11/03
Entrada Therapeutics : Corporate Presentation	04/03
Entrada Therapeutics to Present at Upcoming Investor Conferences	07/02
Entrada Therapeutics Adds President Role to COO Nathan Dowden	03/01
Entrada Therapeutics Adds President Role to COO Nathan Dowden	03/01
Sector Update: Health Care Stocks Gain Pre-Bell Wednesday	03/01
Entrada Therapeutics Promotes Nathan J. Dowden to President	03/01
Entrada Therapeutics Promotes Nathan J. Dowden to President	03/01
Pomerantz Law Firm Investigates Claims On Entrada Therapeutics, Inc. - TRDA	19/12
Entrada Therapeutics, Inc. cancelled the transaction announced on December 7, 2022	07/12
Entrada Therapeutics, Inc. Announces Board Changes	06/12
Pomerantz Law Firm Investigates Claims On Entrada Therapeutics, Inc. - TRDA	29/11
US Equity Markets Close Higher Wednesday Following Consumer Sentiment Data	22/11
Sector Update: Health Care Stocks Advance Late Afternoon	22/11
Health-Related Stocks Extend Gains -- Health Care Roundup	22/11
Top Midday Decliners	22/11

Aucun résultat pour cette recherche